MA vs STRO
Mastercard Inc (MA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MA currently screens at market cap $515.12B and trailing P/E 38.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MA and STRO stock pages for the full models.
Not investment advice.